NHF's Medical and Scientific Advisory Council (MASAC) discussed the role of people with bleeding disorders in SARS-CoV-2 Treatment and Vaccine Trials at NHF's virtual Bleeding Disorders Conference.
NHF President and CEO Leonard Valentino, MD, discusses the role of von Willebrand factor (VWF) in severe cases of COVID-19.
Christi Humphrey, LCSW of Hemophilia of Georgia and Jhon Velasco, MA of NHF discuss the principles of anger and how it works in/through the body.
This webinar will cover pain in the bleeding disorder community in the context of the COVID pandemic.
Many of the charitable organizations you may be familiar also have COVID-19 specific funds.
NHF will continue to provide information and resources to the bleeding disorder community on the COVID-19 pandemic.
In this webinar, Drs. Tammuella Singleton and Tyler Buckner explain what you need to know, and what precautions you need to take if you have hemophilia with an inhibitor.
BioMarin is working with health authorities and governmental regulatory agencies globally, to ensure the safety of all those involved in their clinical trial program, including enrolled participants, investigators, and staff.
Information and techniques you and your family can use to stay healthy during the COVID-19 pandemic.
Many questions and concerns exist in our community and NHF is here to help you navigate the complexities of the pandemic.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car